BML Investment Partners, L.P.

Holdings History for Achilles Therapeutics plc - American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share (ACHL)

Symbol: ACHL
Investment type: Equity / American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share
Latest Disclosed Shares Owned: 4,100,002 shares
Security Ownership %: 10%

BML Investment Partners, L.P. ownership in Achilles Therapeutics plc American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share (ACHL)

13 Feb 2025 - BML Investment Partners, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,100,002 shares of Achilles Therapeutics plc American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share (ACHL). This represents 10% ownership of the company. This is the first filing by BML Investment Partners, L.P. disclosing ownership of Achilles Therapeutics plc American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share (ACHL).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
BML Investment Partners, L.P.	10%		$6,066,773	4,100,002			$1.48	13G/A	31 Dec 2024	13 Feb 2025, 17:02